| Literature DB >> 21960958 |
Carmen Rey-Santano1, Victoria E Mielgo, Elena Gastiasoro, Xabier Murgia, Hector Lafuente, Estibaliz Ruiz-Del-Yerro, Adolf Valls-I-Soler, Enrique Hilario, Francisco J Alvarez.
Abstract
The hemodynamic, metabolic, and biochemical changes produced during the transition from fetal to neonatal life may be aggravated if an episode of asphyxia occurs during fetal life. The aim of the study was to examine regional cerebral blood flow (RCBF), histological changes, and cerebral brain metabolism in preterm lambs, and to analyze the role of oxidative stress in the first hours of postnatal life following severe fetal asphyxia. Eighteen chronically instrumented newborn lambs were randomly assigned to either a control group or the hypoxic-ischemic (HI) group, in which case fetal asphyxia was induced just before delivery. All the animals were maintained on intermittent positive pressure ventilation for 3 h after delivery. During the HI insult, the injured group developed acidosis, hypoxia, hypercapnia, lactic acidosis, and tachycardia (relative to the control group), without hypotension. The intermittent positive pressure ventilation transiently improved gas exchange and cardiovascular parameters. After HI injury and during ventilatory support, there continued to be an increased RCBF in inner regions among the HI group, but no significant differences were detected in cortical flow compared to the control group. Also, the magnitude of the increase in TUNEL positive cells (apoptosis) and antioxidant enzymes, and decrease of ATP reserves was significantly greater in the brain regions where the RCBF was not higher. In conclusion, our findings identify early metabolic, histological, and hemodynamic changes involved in brain damage in premature asphyxiated lambs. Such changes have been described in human neonates, so our model could be useful to test the safety and the effectiveness of different neuroprotective or ventilation strategies applied in the first hours after fetal HI injury.Entities:
Keywords: apoptosis; hypoxic–ischemic injury; perinatal life; premature fetal lamb; total and regional cerebral blood flow
Year: 2011 PMID: 21960958 PMCID: PMC3176408 DOI: 10.3389/fnins.2011.00111
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Gas exchange, arterial oxygen content, cerebral oxygen consumption, and oxygen delivery.
| Fetal life | Postnatal life | Two-way ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | HI | 15 min | 30 min | 60 min | 90 min | 120 min | 150 min | 180 min | ||||
| pH | Control | 7.3 ± 0.06 | 7.30 ± 0.06 | 7.05 ± 0.07 | 7.12 ± 0.11 | 7.27 ± 0.17 | 7.28 ± 0.17 | 7.38 ± 0.15 | 7.43 ± 0.15 | 7.43 ± 0.13 | 7.37 ± 0.11 | |
| HI | 7.3 ± 0.06 | 7.07 ± 0.04* | 6.89 ± 0.12* | 7.02 ± 0.15 | 7.11 ± 0.11 | 7.18 ± 0.09 | 7.26 ± 0.13 | 7.32 ± 0.12 | 7.33 ± 0.09 | 7.28 ± 0.08 | ||
| df:90 | ||||||||||||
| Control | 49 ± 6 ( | 49 ± 6 ( | 87 ± 15 ( | 72 ± 16 ( | 54 ± 22 ( | 43 ± 17 ( | 42 ± 14 ( | 35 ± 11 ( | 38 ± 12 ( | 45 ± 15 ( | ||
| HI | 54 ± 13 ( | 68 ± 16* ( | 116 ± 30 ( | 79 ± 23 ( | 65 ± 19 ( | 68 ± 15* ( | 60 ± 29 ( | 50 ± 16 ( | 49 ± 8 ( | 60 ± 19 ( | ||
| df:90 | ||||||||||||
| Control | 25 ± 6 ( | 27 ± 5 ( | 32 ± 11 ( | 38 ± 10 ( | 72 ± 45 ( | 92 ± 32 ( | 47 ± 20 ( | 80 ± 22 ( | 95 ± 50 ( | 58 ± 20 ( | ||
| HI | 23 ± 6 ( | 18 ± 5* ( | 25 ± 8 ( | 38 ± 15 ( | 42 ± 20 ( | 47 ± 32* ( | 65 ± 18 ( | 41 ± 21* ( | 35 ± 11* ( | 24 ± 7* ( | ||
| df:72 | ||||||||||||
| Control | 7 ± 3 ( | 7 ± 3 ( | 9 ± 4 ( | 11 ± 4 ( | 14 ± 3 ( | 15 ± 3 ( | 14 ± 3 ( | 15 ± 3 ( | 14 ± 3 ( | 13 ± 3 ( | ||
| HI | 6 ± 3 ( | 4 ± 2* ( | 7 ± 4 ( | 12 ± 4 ( | 11 ± 4 ( | 11 ± 4 ( | 12 ± 4 ( | 10 ± 5 ( | 10 ± 5* ( | 6 ± 3* ( | ||
| df:72 | ||||||||||||
| Control | 2.5 ± 1.7 ( | 2.3 ± 1.2 ( | 4.5 ± 2.6 ( | 5 ± 2 ( | 4.5 ± 1.8 ( | 3.8 ± 1.0 ( | 2.9 ± 0.9 ( | 3.7 ± 1.1 ( | 4.0 ± 1.6 ( | 3.7 ± 1.1 ( | ||
| HI | 2.3 ± 1.8 ( | 2.0 ± 1.7 ( | 3.2 ± 3.5 ( | 3 ± 1 ( | 4.3 ± 2.7 | 4.1 ± 2.2 ( | 4.6 ± 2.3 ( | 3.7 ± 2.2 ( | 3.3 ± 1.7 ( | 1.9 ± 1.2 * ( | ||
| df:72 | ||||||||||||
| OD (mL/min) | Control | 4.8 ± 3 ( | 4.4 ± 2.3 ( | 10.2 ± 5.5 ( | 9.3 ± 2.1 ( | 8.3 ± 5.3 ( | 6.8 ± 3.0 ( | 7.3 ± 5.5 ( | 8.6 ± 6.3 ( | 8.1 ± 5.5 ( | 8.0 ± 3.0 ( | |
| HI | 5.0 ± 3.3 ( | 5.3 ± 2.8 ( | 8.8 ± 7.2 ( | 7.9 ± 4.2 ( | 9.2 ± 6.9 ( | 8.6 ± 3.9 ( | 9.5 ± 5.2 ( | 7.6 ± 4.6 ( | 6.7 ± 3.5 ( | 4.2 ± 2.3* ( | ||
| df:72 | ||||||||||||
Data are expressed as mean ± SD. B, baseline fetal time point; HI, hypoxic–ischemic time point; V, time point of connection to a ventilator; ;
, cerebral oxygen consumption; OD, oxygen delivery. *.
Hemodynamic parameters and ventilation indices.
| Fetal life | Postnatal life | Two-way ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | HI | V | 15 min | 30 min | 60 min | 90 min | 120 min | 150 min | 180 min | |||
| MABP (mmHg) | Control | 56 ± 8 ( | 56 ± 8 ( | 81 ± 9 ( | 67 ± 9 ( | 64 ± 8 ( | 65 ± 9 ( | 64 ± 18 ( | 64 ± 10 ( | 57 ± 3 ( | 60 ± 14 ( | |
| HI | 56 ± 6 ( | 57 ± 5 ( | 74 ± 7 ( | 58 ± 12 ( | 56 ± 13 ( | 52 ± 9* ( | 60 ± 19 ( | 58 ± 13 ( | 54 ± 8 ( | 45 ± 14 ( | ||
| df:90 | ||||||||||||
| HR (beat/min) | Control | 159 ± 35 ( | 159 ± 35 ( | 187 ± 20 ( | 186 ± 35 ( | 151 ± 28 ( | 150 ± 20 ( | 151 ± 21 ( | 182 ± 12 ( | 179 ± 45 ( | 207 ± 54 ( | |
| HI | 167 ± 25 ( | 236 ± 14* ( | 224 ± 8* ( | 188 ± 28 ( | 178 ± 21 ( | 162 ± 19 ( | 194 ± 39 ( | 230 ± 40 ( | 258 ± 27 ( | 257 ± 17* ( | ||
| df:90 | ||||||||||||
| CBF (mL/min) | Control | 71 ± 22 | 59 ± 12 ( | 114 ± 22 ( | 104 ± 30 ( | 61 ± 33 ( | 45 ± 16 ( | 49 ± 26 ( | 55 ± 29 ( | 54 ± 29 ( | 61 ± 13 ( | |
| HI | 69 ± 24 | 117 ± 28* ( | 110 ± 48 ( | 87 ± 48 ( | 82 ± 42 ( | 76 ± 27* ( | 80 ± 35 ( | 74 ± 30 ( | 64 ± 15 ( | 65 ± 21 ( | ||
| df:90 | ||||||||||||
| OI | Control | – | – – | 40 ± 24 ( | 37 ± 19 ( | 17 ± 7 ( | 12 ± 4 ( | 17 ± 4 ( | 14 ± 4 ( | 13 ± 5 ( | 19 ± 7 ( | |
| HI | 45 ± 15 ( | 38 ± 18 ( | 31 ± 13* ( | 32 ± 18* ( | 27 ± 10 ( | 33 ± 15* ( | 33 ± 10* ( | 49 ± 14* ( | ||||
| df:11 | df:11 | df:11 | df:70 | |||||||||
| VEI | Control | – | – – | 0.04 ± 0.01 ( | 0.05 ± 0.03 ( | 0.08 ± 0.04 ( | 0.10 ± 0.07 ( | 0.14 ± 0.10 ( | 0.14 ± 0.10 ( | 0.17 ± 0.11 ( | 0.17 ± 0.11 ( | |
| HI | 0.03 ± 0.01 ( | 0.06 ± 0.03 ( | 0.06 ± 0.02 ( | 0.05 ± 0.02 ( | 0.07 ± 0.02 ( | 0.08 ± 0.04 ( | 0.08 ± 0.03 ( | 0.08 ± 0.05 ( | ||||
| df:90 | ||||||||||||
Data are expressed as mean ± SD. B, fetal baseline time point; HI, hypoxic–ischemic time point; V, time point of connection to a ventilator; MABP, mean arterial blood pressure; HR, heart rate; CBF, cerebral blood flow; OI, oxygenation index; VEI, ventilation efficiency index. *.
For MABP, HR, and CBF parameters six subjects per group along the 10 time points were considered. For OI and VEI parameters, six subjects per group along the eight time points were considered.
Figure 1Regional cerebral blood flow (mL 100g. Data are expressed as mean ± SD. Mean values for both control (open square) and hypoxic–ischemic (close square) groups are represented as function of time; Baseline (B), Hypoxic–Ischemic (HI), 60 and 180 min points. *p < 0.05 vs. control group (one-factor ANOVA).
Figure 3(A) Number of apoptotic cells·mm−2. (B) Regional cerebral blood flow (mL 100g−1 min−1). (C) ATP concentration (mmol g−1) as function of brain region and experimental group. Data are expressed as mean ± SD. *p < 0.05 vs. control group (one-factor ANOVA).
Figure 2Histological analysis. (A) View of the brain stem 3 h after hypoxic–ischemic injury. Presence of large eosinophilic neurons (arrows). Hematoxylin–eosin stain. Original magnification × 200. (B) Cells with apoptotic morphology figures (arrow) in the basal ganglia of the hypoxic–ischemic group. On the left (arrowhead), damaged neurons with a negative stain for TUNEL can also be observed. TUNEL counterstained with methyl green. Original magnification × 400.
Figure 4Antioxidant enzymes activity (U μg. (A) SOD activity. (B) Catalase activity. (C) GSH-Px activity as function of different brain regions and experimental group. *p < 0.05 vs. control group (one-factor ANOVA).